Anti-ANGPT2 (MEDI3617)

Anti-ANGPT2 (MEDI3617) is a human IgG1 kappa monoclonal antibody directed against the angiogenic cytokines angiopoietin-2 (Angpt2). MEDI3617 in combination with tremelimumab is used to treat advanced melanoma. MW: 145.82 kD.
Supplier Selleck Chemicals
Product # A2770
Sku # A2770-1mg*5
Pricing 1mg*5, $1690.00
Feedback